Development of Prophylactics and Therapeutics Against the Smallpox and Monkeypox Biothreat Agents

被引：3
|
作者：
Buller, Mark [1 ]
Handley, Lauren [1 ]
Parker, Scott [1 ]
机构：
[1] St Louis Univ, Hlth Sci Ctr, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA
来源：
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NIH, VOL 1: FRONTIERS IN RESEARCH | 2008年
关键词：
D O I：
10.1007/978-1-59745-569-5_17
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：145 / 161
页数：17
相关论文
共 50 条
  • [1] A Mouse Model of Lethal Infection for Evaluating Prophylactics and Therapeutics against Monkeypox Virus
    Stabenow, Jennifer
    Buller, R. Mark
    Schriewer, Jill
    West, Cheri
    Sagartz, John E.
    Parker, Scott
    [J]. JOURNAL OF VIROLOGY, 2010, 84 (08) : 3909 - 3920
  • [2] Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections
    Baker, R
    Bray, M
    Huggins, JW
    [J]. ANTIVIRAL RESEARCH, 2003, 57 (1-2) : 13 - 23
  • [3] Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections
    Baker, RO
    Bray, M
    Herrera, R
    Huggins, JW
    [J]. ANTIVIRAL RESEARCH, 2002, 53 (03) : A63 - A63
  • [4] Is smallpox vaccination protective against human monkeypox?
    Mileto, Davide
    Farinacci, Damiano
    Pozza, Giacomo
    Ciccullo, Arturo
    Cossu, Maria Vittoria
    Giacomelli, Andrea
    Borgonovo, Fabio
    Mileto, Davide
    Santangelo, Rosaria
    Tamburrini, Enrica
    Rizzardini, Giuliano
    Antinori, Spinello
    Giambenedetto, Simona Di
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)
  • [5] Candidate Vaccines and Therapeutics against Monkeypox Infection
    Nainwal, Nidhi
    Jakhmola, Vikash
    [J]. JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2022, 16 : 3096 - 3105
  • [6] In Vitro Efficacy of ST246 against Smallpox and Monkeypox
    Smith, Scott K.
    Olson, Victoria A.
    Karem, Kevin L.
    Jordan, Robert
    Hruby, Dennis E.
    Damon, Inger K.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (03) : 1007 - 1012
  • [7] Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics
    Zhao, Shaojuan
    Zhang, Huajun
    Yang, Xinglou
    Zhang, Haiwei
    Chen, Ying
    Zhan, Yancheng
    Zhang, Xiaoqing
    Jiang, Rendi
    Liu, Meiqin
    Liu, Lan
    Chen, Li
    Tang, Wei
    Peng, Cheng
    Gao, Xiaoxiao
    Zhang, Zhe
    Shi, Zhengli
    Gong, Rui
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [8] Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics
    Shaojuan Zhao
    Huajun Zhang
    Xinglou Yang
    Haiwei Zhang
    Ying Chen
    Yancheng Zhan
    Xiaoqing Zhang
    Rendi Jiang
    Meiqin Liu
    Lan Liu
    Li Chen
    Wei Tang
    Cheng Peng
    Xiaoxiao Gao
    Zhe Zhang
    Zhengli Shi
    Rui Gong
    [J]. Nature Communications, 12
  • [9] Some Possibilities to Study New Prophylactics against Nerve Agents
    Bajgar, J.
    Kassa, J.
    Kucera, T.
    Musilek, K.
    Jun, D.
    Kuca, K.
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2019, 19 (12) : 970 - 979
  • [10] Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox
    Patricia L. Earl
    Jeffrey L. Americo
    Linda S. Wyatt
    Leigh Anne Eller
    J. Charles Whitbeck
    Gary H. Cohen
    Roselyn J. Eisenberg
    Christopher J. Hartmann
    David L. Jackson
    David A. Kulesh
    Mark J. Martinez
    David M. Miller
    Eric M. Mucker
    Joshua D. Shamblin
    Susan H. Zwiers
    John W. Huggins
    Peter B. Jahrling
    Bernard Moss
    [J]. Nature, 2004, 428 : 182 - 185
12345